ERBB2 and breast cancer: Recently, a marked molecular heterogeneity of breast cancer has also been demonstrated by gene expression profiling studies, which identified four major BC “intrinsic” subtypes, including luminal A, luminal B, HER2-enriched, and basal-like, showing variable biological, clinical behaviors and response to treatment [2, 3].